Opendata, web and dolomites


Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies

Total Cost €


EC-Contrib. €






 NovAnI project word cloud

Explore the words cloud of the NovAnI project. It provides you a very rough idea of what is the project "NovAnI" about.

identification    methicillin    der    drugs    negative    antibacterial    emergence    crystallographers    hit    difficult    biochemical    importers    energy    anti    position    resistance    expertise    circumventing    million    medicinal    pathogens    me    dnan    peculiar    platform    resistant    diseases    fact    staphylococcus    dxs    serious    sliding    transporters    chemistry    antituberculotic    gram    crossing    selectivity    threat    organic    biosynthetic    few    bacteria    urgently    combination    aureus    dna    given    first    deaths    molecule    pharmacologists    agent    flexibility    humans    place    action    erc    interdisciplinary    un    health    potentially    goals    explored    synergistic    cell    coupling    employing    unconventional    thereby    polymerase    incidence    positive    absent    vitamin    rapid    scaffolds    small    mycobacterium    infectives    builds    agents    excellent    edge    clamp    give    drug    infective    context    mrsa    mode    exhaustion    infections    antimalarial    protein    provides    repair    strategies    inhibitors    tuberculosis    wall    investment    causative    return    biochemists    synthetic    collaborations    cutting   

Project "NovAnI" data sheet

The following table provides information about the project.


Organization address
postcode: 38124

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙499˙367 €
 EC max contribution 1˙499˙367 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Given the rapid emergence of anti-infective resistance, drugs with a novel mode of action are urgently needed. Because of an exhaustion of existing strategies, a low return on investment and the fact that anti-infectives are difficult to develop (e.g., crossing the peculiar cell wall of Mycobacterium tuberculosis), promising un(der)explored targets and unconventional hit-identification strategies are needed.

I have selected three anti-infective targets based on their biochemical context for which few or no small-molecule inhibitors are known:

1) The antimalarial and antituberculotic drug target DXS is part of a unique biosynthetic pathway for pathogens that is absent in humans, thereby circumventing selectivity issues. Both diseases are a serious health threat with around 1.9 million deaths per year. 2) Energy-coupling factor transporters are essential vitamin importers for pathogens such as Staphylococcus aureus, the causative agent of methicillin-resistant Staphylococcus aureus (MRSA) infections. 3) The DNA polymerase sliding clamp DnaN has polymerase and DNA repair activities and is an excellent drug target for the development of antibacterial agents against Gram-negative and –positive bacteria given the low incidence of resistance development.

I will address these targets, employing a unique combination of potentially synergistic hit-identification strategies that take into account protein flexibility, provide access to novel scaffolds and give me a cutting edge for the development of novel anti-infectives.

This ERC proposal builds on my experience with the first two targets and provides an excellent platform for the new target DnaN. My expertise in synthetic organic and medicinal chemistry and established hit-identification strategies together with my collaborations with protein crystallographers, biochemists and pharmacologists place me in an excellent position for not only achieving the goals of this interdisciplinary proposal but also going beyond it.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NOVANI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NOVANI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  

EVOMENS (2020)

The evolution of menstruation in primates

Read More  


The Mass Politics of Disintegration

Read More